What are the ethical considerations when a patient experiences adverse effects from a medication, but wishes to continue treatment due to its therapeutic benefits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The ethical consideration in this scenario prioritizes patient autonomy while ensuring the healthcare provider's duty of beneficence and nonmaleficence, necessitating a balanced approach that respects the patient's preferences and values while minimizing harm. When a patient wishes to continue a medication despite experiencing side effects, the provider should engage in transparent discussions about the nature and severity of these side effects, potential long-term consequences, and available alternatives. This process involves assessing whether the side effects pose serious health risks that might outweigh the benefits of continued medication use.

Key Considerations:

  • The patient's right to make informed decisions about their care must be respected, ensuring they fully understand the risks and benefits involved 1.
  • The provider should evaluate whether the side effects are manageable and not life-threatening, and if the patient values the symptom relief they are experiencing, continuing the medication with close monitoring may be appropriate.
  • If the side effects present significant dangers, the provider has an ethical obligation to strongly recommend alternatives, respecting the patient's preferences within the context of shared decision-making.
  • Patient factors, including preferences, comorbidities, and changes in treatment goals, should guide medication adjustments, as highlighted in the management of conditions like diabetes 1 and hypertension 1.
  • The goal is to maintain therapeutic benefits while minimizing adverse effects, which may involve adjusting the treatment regimen based on individual patient needs and responses to therapy. Given the most recent and highest quality evidence, the approach should prioritize shared decision-making, emphasizing patient-centered care that balances the benefits of treatment against potential risks and side effects 1.

From the Research

Ethical Considerations

The patient's insistence on continuing a medication despite reported side effects raises several ethical considerations, including:

  • The patient's autonomy and right to make informed decisions about their own care 2
  • The potential benefits of the medication in managing the patient's symptoms, weighed against the potential risks and harms associated with continued use 3
  • The importance of ongoing monitoring and evaluation to minimize the risk of adverse effects and optimize treatment outcomes 4

Patient-Centered Care

A patient-centered approach to care involves:

  • Respecting the patient's autonomy and involving them in decision-making about their care 5
  • Providing education and support to help the patient understand their treatment options and make informed decisions 6
  • Collaborating with other healthcare professionals, such as pharmacists, to ensure comprehensive and coordinated care 2

Medication Management

Effective medication management involves:

  • Regular review and monitoring of the patient's medication regimen to minimize the risk of adverse effects and optimize treatment outcomes 2, 3
  • Simplification of the medication regimen, where possible, to improve adherence and reduce the risk of errors 5
  • Ongoing evaluation and adjustment of the treatment plan as needed to ensure that the patient's needs are being met 4, 6

Related Questions

What are the potential interactions or concerns with a regimen including ABITREN TEVA (Abitren) 75mg/3ml, AZILECT (Rasagiline) 1mg, BONDORMIN 0.25mg, CALCI CHEW D3-SP, ENALADEX 5mg, EZECOR 10mg, RIBONE 150mg, SERENADA 100mg, SIFROL ER 0.75mg, SILVEROL CRM 1%, STALEVO 100mg and 75mg, and VASODIP 10mg, considering interactions with baclofen?
What is the proper dosage and administration schedule for a patient taking a 3 mg-0.03 mg tablet, possibly a birth control pill?
What is the workup for a 54-year-old male experiencing recurrent headaches (HAs), dry cough, and severe neck and rear headaches during climax, with a history of hypertension (HTN) and tinnitus, currently taking lisinopril (Lisinopril)-hydrochlorothiazide (HCTZ), and previously taking amlodipine (Amlodipine) and losartan (Losartan)-amlodipine, with an upcoming magnetic resonance imaging (MRI) of the brain?
Which medications should be adjusted to improve energy in a depressed patient taking trazodone and bupropion?
What is the optimal management plan for a 70-year-old male with End-Stage Renal Disease (ESRD) on Hemodialysis (HD), resistant Hypertension (HTN), Heart Failure with preserved Ejection Fraction (HFpEF), Coronary Artery Disease (CAD), Gastroesophageal Reflux Disease (GERD), and Type 2 Diabetes Mellitus (T2DM), who presents with improved symptoms after hospital discharge for hypertensive urgency and hematemesis, and is currently taking carvedilol (Coreg) (carvedilol), lisinopril (Zestril) (lisinopril), amlodipine (Norvasc) (amlodipine), doxazosin (Cardura) (doxazosin), hydralazine (Apresoline) (hydralazine), and furosemide (Lasix) (furosemide)?
What intervention is considered for a pregnant woman with severe depression when medication and psychotherapy are insufficient?
What is the next step in treatment for a patient with rapid cycling bipolar disorder who is not responding to Valproate (valproic acid) according to American Psychiatric Association (APA) guidelines?
What is the next step for a patient on carbamazepine (an anticonvulsant and mood stabilizer) for bipolar disorder who develops symptoms of dizziness and diplopia (double vision)?
What is the first-line treatment for a patient with bipolar disorder presenting with a severe depressive episode according to the American Psychological Association (APA) guidelines?
What medication is considered first-line for opioid use disorder treatment according to the American Society of Addiction Medicine (ASAM) guidelines?
What non-pharmacological treatment options are suitable for a patient with chronic pain and comorbid depression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.